Drug Trial Radar · NCT05857930
A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
296
Actual
Start
Jun 20, 2023
Primary completion
Sep 15, 2026
Study completion Sep 15, 2026
Sponsor
- Lead sponsor
- OM Pharma SAIndustry
- Sponsor type
- Industry
- First posted
- May 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 72 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing
Conditions
- Recurrent Wheezing
- Wheezing Lower Respiratory Illness
Interventions
OM-85Drug
OM-85 capsule (3.5mg) contents will be mixed with adequate quantity of water, fruit juice or milk/formula and orally administered once a day for 6 consecutive months.
PlaceboDrug
Placebo capsule contents will be mixed with adequate quantity of water, fruit juice or milk/formula and orally administered once a day for 6 consecutive months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Wheezing/Asthma like episodes (WEs)Time frame: 6 Months
Locations
38 sites in 4 countries. Site status is shown where the registry gives one.
Arizona Medical Clinic
Phoenix, Arizona
Phoenix Children's Hospital
Phoenix, Arizona
The University of Arizona Medical Center - University Campus
Tucson, Arizona
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas
Kern Research Inc.
Bakersfield, California
Hoag Health Center Foothill Ranch
Foothill Ranch, California
UCSF Benioff Children's Hospital Oakland Primary Care Clinic
Oakland, California
Allergy & Asthma Medical Group and Research (AAMGRC) - Allergy, Asthma and Immunology
San Diego, California
Rady Children's Hospital
San Diego, California
Children's Hospital Colorado - Pediatric Heart Lung Center - Pediatrics
Aurora, Colorado
BioMD Clinical Research
Coral Gables, Florida
American Research Institute, INC
Cutler Bay, Florida
C & R Research Services USA. Inc
Miami, Florida
Rush University Medical Center
Chicago, Illinois
Riley Children's Health - Pediatrics
Indianapolis, Indiana
Allergy & Asthma Specialists PSC
Owensboro, Kentucky
Velocity Clinical Research - Lafayette
Lafayette, Louisiana
Boston Children's Hospital
Boston, Massachusetts
Velocity Clinical Research - Binghamton
Binghamton, New York
Northwell Health/Division of Allergy & Immunology
Great Neck, New York
UNC Hospitals, The Univ of NC at Chapel Hill
Chapel Hill, North Carolina
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio
Allergy, Asthma and Clinical Research Center
Oklahoma City, Oklahoma
Vital Prospects Clinical Research Institute, PC
Tulsa, Oklahoma
Monroe Carell Jr. Children's Hospital
Nashville, Tennessee
Helios Clinical Research - Houston
Houston, Texas
La Providence Pediatrics Clinic
Houston, Texas
Prime Clinical Research Inc
Mansfield, Texas
STAAMP Research
San Antonio, Texas
The University of Texas Health Science Center at Tyler - Pulmonology
Tyler, Texas
University of Wisconsin School of Medicine & Public Health - allergy, Pulmonary, & Critical Care Medicine
Madison, Wisconsin
University Hospital Geelong - Barwon Health
Geelong, Victoria, Australia
The Royal Childrens Hospital
Melbourne, Victoria, Australia
Borsod-Abauj-Zemplen Varmegyei Kozponti Korhaz
Miskolc, Borsod-Abauj Zemplen county, Hungary
Aranyklinika Kft.
Szeged, Csongrád megye, Hungary
ALERGO-MED Specjalistyczna Przychodnia Lekarska Sp.z o. o.
Tarnów, Lesser Poland Voivodeship, Poland
Velocity Skierniewice Sp. z o.o.
Skierniewice, Łódź Voivodeship, Poland
NZOZ E-Vita
Bialystok, Podlaskie Voivodeship, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.